[go: up one dir, main page]

BR0314964A - Método de aumento das habilidades cognitivas - Google Patents

Método de aumento das habilidades cognitivas

Info

Publication number
BR0314964A
BR0314964A BR0314964-1A BR0314964A BR0314964A BR 0314964 A BR0314964 A BR 0314964A BR 0314964 A BR0314964 A BR 0314964A BR 0314964 A BR0314964 A BR 0314964A
Authority
BR
Brazil
Prior art keywords
cognitive skills
increasing cognitive
effective amount
synergistically effective
extract
Prior art date
Application number
BR0314964-1A
Other languages
English (en)
Inventor
Valter Gianesello
Fabio Soldati
Alberto Vignutelli
Markus Peters
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32044192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0314964(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE20215011U external-priority patent/DE20215011U1/de
Priority claimed from EP03005568A external-priority patent/EP1457209A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0314964A publication Critical patent/BR0314964A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/60—Edible seaweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)

Abstract

"MéTODO DE AUMENTO DAS HABILIDADES COGNITIVAS". A presente invenção refere-se a um método para melhorar as habilidades cognitivas de uma pessoa através da administração de uma composição compreendendo (i) uma quantidade sinergisticamente eficaz de um extrato da planta Panax ginseng; e (ii) uma quantidade sinergisticamente eficaz de um extrato da planta Paullinia cupana.
BR0314964-1A 2002-09-28 2003-09-26 Método de aumento das habilidades cognitivas BR0314964A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE20215011U DE20215011U1 (de) 2002-09-28 2002-09-28 Nahrungsergänzungsmittel bzw. Energiemix, auf der Basis von Vitaminen, Mineralstoffen, Spurenelementen und Koffein in Form eines Guarana-Extrakts, welches grundsätzlich in einer Tagesdosis verpackt ist
EP03005568A EP1457209A1 (en) 2003-03-12 2003-03-12 Composition for the enhancement of cognitive skills comprising Panax ginseng and Paullinia cupana extracts
PCT/EP2003/010749 WO2004028550A2 (en) 2002-09-28 2003-09-26 Composition comprising panax ginseng and paullinia cupana extracts

Publications (1)

Publication Number Publication Date
BR0314964A true BR0314964A (pt) 2005-08-02

Family

ID=32044192

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314964-1A BR0314964A (pt) 2002-09-28 2003-09-26 Método de aumento das habilidades cognitivas

Country Status (16)

Country Link
US (1) US20050202104A1 (pt)
EP (1) EP1545569B1 (pt)
JP (1) JP2006503844A (pt)
KR (1) KR20050047130A (pt)
CN (1) CN100411655C (pt)
AU (1) AU2003267419B2 (pt)
BR (1) BR0314964A (pt)
CA (1) CA2500154C (pt)
CO (1) CO5640141A2 (pt)
EC (1) ECSP055706A (pt)
MX (1) MXPA05003285A (pt)
NZ (2) NZ539658A (pt)
PL (1) PL218910B1 (pt)
RU (2) RU2355192C2 (pt)
WO (1) WO2004028550A2 (pt)
ZA (1) ZA200502030B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2882896B1 (fr) * 2005-03-14 2007-05-04 Larena Sa Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees
RU2323599C1 (ru) * 2006-10-13 2008-05-10 Татьяна Львовна Пилат Биологически активная добавка к пище и способ ее получения
CN100475273C (zh) * 2007-01-08 2009-04-08 广东省微生物研究所 一种室内空气消毒剂
KR20080105470A (ko) * 2007-05-31 2008-12-04 (주)아모레퍼시픽 인삼 열매 추출물을 함유하는 비만 예방 및 개선용 식품조성물
US20090155392A1 (en) * 2007-12-17 2009-06-18 Bret David Nelson Methods and Systems for Sublingual Guarana Administration
BRPI1101146A2 (pt) 2011-03-31 2013-05-28 Luiz Francisco Pianowski fraÇço ativa de paullinia cupana com atividade aprimorada no combate À fadiga, processo de produÇço de uma fraÇço ativa, uso, composiÇço farmacÊutica, medicamento e mÉtodo de tratamento de fadiga
US8840937B2 (en) * 2011-08-02 2014-09-23 Walter Joe FORD, JR. Composition and method for recovery from mild traumatic brain injury
MY181972A (en) * 2012-03-28 2021-01-15 Taiko Pharmaceutical Co Ltd Drug composition and soft capsule drug sealing the drug composition
IL226913B (en) * 2012-06-13 2020-01-30 Inno Bev Ltd Composition comprising natural extracts
FR3025700B1 (fr) 2014-09-12 2016-11-04 Bruno Obriot Procede de fabrication d'un complement alimentaire a base d'huiles essentielles en poudre
AU2015340534A1 (en) * 2014-10-31 2017-04-20 Spherium Biomed S.L. Combination for the treatment of conditions involving muscular pain
RU2635573C1 (ru) * 2016-10-31 2017-11-14 Василий Григорьевич Густинович Пищевая добавка
IT201700123873A1 (it) * 2017-10-31 2019-05-01 Erba Vita Group S P A Una bibita comprendente ingredienti solo di origine naturale
RU2679634C1 (ru) * 2018-09-07 2019-02-12 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Способ получения СО2 экстракта женьшеня
WO2020209427A1 (ko) * 2019-04-12 2020-10-15 주식회사 비엔지삶 팔미라팜, 인삼, 및 아티초크를 유효성분으로 포함하는 식품 조성물, 이를 이용한 발포정, 및 이의 제조방법
GB202012338D0 (en) * 2020-08-07 2020-09-23 Givaudan Sa Extraction method
KR20220041656A (ko) 2020-09-25 2022-04-01 경희대학교 산학협력단 미삼 나노분쇄액 동결건조분말을 이용한 인지능력 및 기억력 개선용 조성물 및 그 제조방법
KR20220041655A (ko) 2020-09-25 2022-04-01 경희대학교 산학협력단 미삼 농축추출물을 이용한 인지능력 및 기억력 개선용 조성물 및 이의 제조방법
KR102284681B1 (ko) 2020-10-27 2021-07-30 윤정희 미삼을 이용한 부대찌개 소스 및 그의 제조방법
RU2764076C1 (ru) * 2021-06-03 2022-01-13 Общество с ограниченной ответственностью "Академия-Т" Биологически активная добавка к пище
CN117858629A (zh) * 2021-06-25 2024-04-09 可口可乐公司 具有植物提取物的口服消费品组合物
WO2023183759A2 (en) * 2022-03-24 2023-09-28 Mdm Enterprise Solutions Inc. Adaptogen formulations and methods of use
KR20250022690A (ko) * 2022-06-16 2025-02-17 마이크로파이트 인지 능력을 향상시키기 위한 미세조류 추출물의 단독 또는 병용 용도
FR3148356B1 (fr) 2023-05-02 2025-11-14 Vinpai Procédé de fabrication d’un complément alimentaire en poudre à base d’huiles essentielles liquides.
KR102899522B1 (ko) * 2025-03-05 2025-12-12 주식회사 커피도슨트 수면 유도 또는 수면 질을 향상용 커피 티백 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
JP2869991B2 (ja) * 1989-01-30 1999-03-10 トヨタ自動車株式会社 Ｆｍｓラインにおける生産指示方法およびその装置
JPH05213763A (ja) * 1992-02-10 1993-08-24 Sanwa Kagaku Kenkyusho Co Ltd 易吸収活性化カルシウム製剤
LU88375A1 (fr) * 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Produit énergétique stimulant la puissance virile
FR2712191B1 (fr) * 1993-11-08 1996-03-08 Bioes Laboratoires Composition pharmaceutique ou diététique associant du ginseng et du guarana.
GB2285578A (en) * 1993-12-22 1995-07-19 Leilani Lea Beverages containing added guaranine
CN1131521A (zh) * 1995-12-04 1996-09-25 蔡东明 草珊瑚清凉饮料配方及其制备工艺
IT1293539B1 (it) * 1997-07-16 1999-03-01 Sigma Tau Ind Farmaceuti Composizione nutritiva per soggetti in stato di debilitazione causato da stress
US5925377A (en) * 1997-08-07 1999-07-20 Nova Pharmaceutical Co. Dietary supplement composition
TR200001631T2 (tr) * 1997-12-08 2000-11-21 Natural Medico Tech A/S Ağırlık azaltmak için kompozisyonlar.
TWI247585B (en) * 1999-05-14 2006-01-21 Takara Bio Inc Agarobiose-containing composition
WO2001005244A1 (en) * 1999-07-19 2001-01-25 Kyowa Hakko Kogyo Co., Ltd. Feeds and foods for treating or preventig disease accompanying aging, method for feeding klotho mutant homoanimal and feeds therefor
AU3885201A (en) * 1999-09-20 2001-04-24 Mastercare Diet and weight control gum and sucker
EP1242105B3 (en) * 1999-12-17 2009-08-12 Pharmaton S.A. Combination of ginseng and ginkgo to improve cognitive skills
KR100375018B1 (ko) * 2000-01-31 2003-03-06 (주) 디지탈바이오텍 인삼 추출물을 함유하는 뇌의 해마 시냅스 형성 촉진제
US6399116B1 (en) * 2000-04-28 2002-06-04 Rulin Xiu Rhodiola and used thereof
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
JP2002029981A (ja) * 2000-07-13 2002-01-29 Mie Kariyou Kk 向知性素材
DE10140320A1 (de) * 2001-08-16 2003-03-06 Udo Zirfas Potenzfördernder und vitaltonisierender Wirkstoff

Also Published As

Publication number Publication date
RU2008109312A (ru) 2009-09-20
ZA200502030B (en) 2005-11-30
CO5640141A2 (es) 2006-05-31
MXPA05003285A (es) 2005-07-05
RU2355192C2 (ru) 2009-05-20
EP1545569A2 (en) 2005-06-29
RU2005113164A (ru) 2006-01-27
EP1545569B1 (en) 2016-12-14
NZ539658A (en) 2007-03-30
AU2003267419A1 (en) 2004-04-19
PL218910B1 (pl) 2015-02-27
HK1084868A1 (en) 2006-08-11
CN100411655C (zh) 2008-08-20
AU2003267419B2 (en) 2009-07-02
WO2004028550A2 (en) 2004-04-08
PL374950A1 (pl) 2005-11-14
CA2500154C (en) 2019-01-15
US20050202104A1 (en) 2005-09-15
WO2004028550A3 (en) 2004-06-10
CN1684698A (zh) 2005-10-19
JP2006503844A (ja) 2006-02-02
ECSP055706A (es) 2005-08-11
NZ552688A (en) 2008-11-28
CA2500154A1 (en) 2004-04-08
KR20050047130A (ko) 2005-05-19

Similar Documents

Publication Publication Date Title
BR0314964A (pt) Método de aumento das habilidades cognitivas
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
MX2010002410A (es) Metodo para proveer los beneficios de energia, alivio del estres y mejora del estado de animo, que comprende administrar una composicion que comprende colecalciferol y un extracto de te.
BRPI0408490A (pt) composições que compreendem ácidos graxos e aminoácidos
BRPI0506751B8 (pt) método para isolar uma fração bioativa derivada de suco celular de uma planta de camellia sinensis
WO2008054200A3 (en) Use of nutritional compositions for preventing disorders
NO20042151L (no) Sammensetning for a forbedre skjelettvekst og opprettholdelse av benhelse
BRPI0511322A (pt) composições adequadas para o tratamento de sinais cutáneos provenientes do envelhecimento, tablete e formulação de tablete
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
MX2022015799A (es) Composicion y metodo para el tratamiento del dolor cronico.
ATE459365T1 (de) Verfahren zur behandlung von entzündungserkrankungen mit maracujaextrakten
BRPI0517826A (pt) uso de extratos vegetais para prevenir e/ou reduzir os sinais de desconforto subjetivo e/ou irritação na aplicação tópica de produtos cosméticos
BR0307910A (pt) Composição de soja para equilibrar pele mista
BRPI0418854A (pt) composições herbáceas
AR043564A1 (es) Metodo de potenciacion de las habilidades cognitivas
BRPI0416747A (pt) métodos e formulações para o tratamento de condições médicas relacionadas à dihidrotesterona elevada
TW200724150A (en) Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients
DE502005010502D1 (de) Pharmazeutische Zusammensetzung, Verwendung dieser pharmazeutischen Zusammensetzung zur Herstellung eines Medikaments und/oder eines Nahrungsergänzungmittels zur Behandlung von Übergewicht und/oder Symptomen, die mit Übergewicht einhergehen, beim Menschen oder Säugetier, sowie Verfahren zur Herstellung dieser pharmazeutischen Zusammensetzung
TW200501973A (en) Method of improvement of blood circulation
BRPI0415893A (pt) métodos para tratar insÈnia em um paciente humano em necessidade do mesmo, para tratar insÈnia primária em um paciente humano adulto ou idoso em necessidade do mesmo e para melhorar o funcionamento no horário diurno em um paciente humano em necessidade do mesmo, uso do gaboxadol, e, composição farmacêutica
ATE308333T1 (de) Pharmazeutische zusammensetzung zur behandlung von verfrühter ejakulation und/oder von überempfindlichkeit der sexuellen stimulierung
EP1981517A4 (en) PLANT COMPOSITION
TW200637536A (en) Compositions containing policosanol and theaflavin and their pharmaceutical uses
DE60236299D1 (de) Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe
BRPI0514303A (pt) composição farmacêutica e método para tratar distúrbios neurodegenerativos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PHARMATON S.A. (CH)

Free format text: TRANSFERIDO DE: BOEHRINGER INGELHEIM INTERNATIONAL GMBH

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: A61K 35/78

Ipc: A61K 36/258 (2006.01), A61K 36/77 (2006.01), A61K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]